New Phase I trial aims to evaluate dendritic cell vaccine for glioblastoma multiforme

被引:0
|
作者
Wilkinson, Jonathan
机构
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:229 / 229
页数:1
相关论文
共 50 条
  • [1] New Phase I trial aims to evaluate dendritic cell vaccine for glioblastoma multiforme
    Wilkinson, Jonathan
    [J]. FUTURE ONCOLOGY, 2014, 10 (04) : 504 - 504
  • [2] New Phase I trial aims to evaluate dendritic cell vaccine for glioblastoma multiforme
    Wilkinson, Jonathan
    [J]. FUTURE NEUROLOGY, 2014, 9 (02) : 115 - 115
  • [3] Trials and Tribulations of Cancer Immunotherapy: The Dendritic Cell Vaccine Shows Promise in a Phase I Glioblastoma Multiforme Trial
    Guersel, Demirkan B.
    Schlaff, Cody D.
    Boockvar, John A.
    [J]. NEUROSURGERY, 2012, 71 (06) : N19 - N21
  • [4] Adjuvant Immunotherapy with Whole-Cell Lysate Dendritic Cells Vaccine for Glioblastoma Multiforme: A Phase II Clinical Trial
    Cho, Der-Yang
    Yang, Wen-Kuang
    Lee, Han-Chung
    Hsu, Den-Mei
    Lin, Hung-Lin
    Lin, Shinn-Zong
    Chen, Chun-Chung
    Harn, Horng-Jyh
    Liu, Chun-Lin
    Lee, Wen-Yuan
    Ho, Li-Hui
    [J]. WORLD NEUROSURGERY, 2012, 77 (5-6) : 736 - 744
  • [5] Dendritic cell vaccination combined with temozolomide retreatment: results of a phase I trial in patients with recurrent glioblastoma multiforme
    Hunn, Martin K.
    Bauer, Evelyn
    Wood, Catherine E.
    Gasser, Olivier
    Dzhelali, Marina
    Ancelet, Lindsay R.
    Mester, Brigitta
    Sharples, Katrina J.
    Findlay, Michael P.
    Hamilton, David A.
    Hermans, Ian F.
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2015, 121 (02) : 319 - 329
  • [6] Dendritic cell vaccination combined with temozolomide retreatment: results of a phase I trial in patients with recurrent glioblastoma multiforme
    Martin K. Hunn
    Evelyn Bauer
    Catherine E. Wood
    Olivier Gasser
    Marina Dzhelali
    Lindsay R. Ancelet
    Brigitta Mester
    Katrina J. Sharples
    Michael P. Findlay
    David A. Hamilton
    Ian F. Hermans
    [J]. Journal of Neuro-Oncology, 2015, 121 : 319 - 329
  • [7] Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma
    Phuphanich, Surasak
    Wheeler, Christopher J.
    Rudnick, Jeremy D.
    Mazer, Mia
    Wang, HongQian
    Nuno, Miriam A.
    Richardson, Jaime E.
    Fan, Xuemo
    Ji, Jianfei
    Chu, Ray M.
    Bender, James G.
    Hawkins, Elma S.
    Patil, Chirag G.
    Black, Keith L.
    Yu, John S.
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2013, 62 (01) : 125 - 135
  • [8] Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma
    Surasak Phuphanich
    Christopher J. Wheeler
    Jeremy D. Rudnick
    Mia Mazer
    HongQian Wang
    Miriam A. Nuño
    Jaime E. Richardson
    Xuemo Fan
    Jianfei Ji
    Ray M. Chu
    James G. Bender
    Elma S. Hawkins
    Chirag G. Patil
    Keith L. Black
    John S. Yu
    [J]. Cancer Immunology, Immunotherapy, 2013, 62 : 125 - 135
  • [9] Dendritic cell therapy in glioblastoma multiforme
    Nesselhut, J.
    Nesselhut, T.
    Chang, R.
    Marx, D.
    Brockmann, W.
    Wilke, I.
    Matthes, C.
    Lorenzen, D.
    Stuecker, W.
    Peters, H.
    Lueke, W.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [10] Personalized neoantigen-pulsed autologous dendritic cells vaccine as an adjuvant treatment for patients with newly-diagnosed glioblastoma multiforme: A phase I trial
    Zhang, Yang
    Chi, Xiaohan
    Cheng, Xudong
    Zhang, Yu
    Zhang, Kangna
    Huang, Na
    Ji, Nan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)